Litcius/Paper detail

Topical Application of S1P<sub>2</sub> Antagonist JTE-013 Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice

Jisoo Kang, Ju‐Hyun Lee, Dong‐Soon Im

2020Biomolecules & Therapeutics27 citationsDOIOpen Access PDF

Abstract

antagonist suppressed DNCB-induced atopic dermatitis symptoms and immune responses. These results suggested JTE-013 as a potential therapeutic agent for atopic dermatitis.

Topics & Concepts

Atopic dermatitisMedicineAntagonistImmunoglobulin EImmunologyImmune systemReceptor antagonistAllergyReceptorInternal medicineAntibodyDermatology and Skin DiseasesSphingolipid Metabolism and SignalingAsthma and respiratory diseases
Topical Application of S1P<sub>2</sub> Antagonist JTE-013 Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis in Mice | Litcius